Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158587776> ?p ?o ?g. }
- W2158587776 endingPage "1301" @default.
- W2158587776 startingPage "1299" @default.
- W2158587776 abstract "Docetaxel is one of the most active drugs used to treat breast cancer. The cellular target of docetaxel is the microtubule, specifically the beta-tubulin subunit, that comprises a series of isotypes and that can modulate function. This study has examined the role of alteration in beta-tubulin isotypes in vitro and has sequenced the beta-tubulin gene to determine if there were mutations, both of which may represent important mechanisms of acquired resistance to docetaxel. Breast cancer cells, MCF-7 (oestrogen-receptor positive) and MDA-MB-231, (oestrogen-receptor negative) were made resistant to docetaxel in vitro. Expression of beta-tubulin isotypes (class I, II, III, IVa, IVb, and VI) was determined at the RNA and protein level using RT-PCR and western analysis, respectively. DNA sequencing evaluated the beta-tubulin gene. At the mRNA level, class I, II, III, and IVa beta-tubulin mRNA isotypes were over-expressed in docetaxel-resistant MCF-7 cells when compared with the docetaxel-sensitive parental cells. However, class VI beta-tubulin mRNA isotype expression was decreased in resistant cells. In MDA-MB-231 cells, there was a decrease in expression of the class I and class IVa beta-tubulin mRNA. However, there were increased expressions in class II, IVb, and VI beta-tubulin mRNA isotypes in resistant cells. Western analysis has confirmed corresponding increases in beta-tubulin protein levels in MCF-7 cells. However, in MDA-MB-231 cells, there were decreased protein levels for class II and class III beta-tubulin. This study demonstrates that altered expression of mRNA beta-tubulin isotypes and modulation of beta-tubulin protein levels are associated with acquired docetaxel resistance in breast cancer cells. This allows further understanding and elucidation of mechanisms involved in resistance to docetaxel." @default.
- W2158587776 created "2016-06-24" @default.
- W2158587776 creator A5006031151 @default.
- W2158587776 creator A5063820246 @default.
- W2158587776 creator A5072329928 @default.
- W2158587776 creator A5089810822 @default.
- W2158587776 date "2005-06-09" @default.
- W2158587776 modified "2023-10-02" @default.
- W2158587776 title "Alterations of β‐tubulin isotypes in breast cancer cells resistant to docetaxel" @default.
- W2158587776 cites W110116438 @default.
- W2158587776 cites W1537655275 @default.
- W2158587776 cites W1749876465 @default.
- W2158587776 cites W1963614111 @default.
- W2158587776 cites W1965404941 @default.
- W2158587776 cites W1976033985 @default.
- W2158587776 cites W1976300798 @default.
- W2158587776 cites W1977379434 @default.
- W2158587776 cites W1994345832 @default.
- W2158587776 cites W1996491270 @default.
- W2158587776 cites W1997749844 @default.
- W2158587776 cites W1999917113 @default.
- W2158587776 cites W2012317077 @default.
- W2158587776 cites W2021532682 @default.
- W2158587776 cites W2022915103 @default.
- W2158587776 cites W2047578735 @default.
- W2158587776 cites W2050285145 @default.
- W2158587776 cites W2067578647 @default.
- W2158587776 cites W2078342982 @default.
- W2158587776 cites W2079609491 @default.
- W2158587776 cites W2096301110 @default.
- W2158587776 cites W2105615050 @default.
- W2158587776 cites W2117204942 @default.
- W2158587776 cites W2125089526 @default.
- W2158587776 cites W2128202801 @default.
- W2158587776 cites W2141056749 @default.
- W2158587776 cites W2146973482 @default.
- W2158587776 cites W2157965511 @default.
- W2158587776 cites W2283907399 @default.
- W2158587776 cites W4233358210 @default.
- W2158587776 doi "https://doi.org/10.1096/fj.04-3178fje" @default.
- W2158587776 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15946994" @default.
- W2158587776 hasPublicationYear "2005" @default.
- W2158587776 type Work @default.
- W2158587776 sameAs 2158587776 @default.
- W2158587776 citedByCount "101" @default.
- W2158587776 countsByYear W21585877762012 @default.
- W2158587776 countsByYear W21585877762013 @default.
- W2158587776 countsByYear W21585877762014 @default.
- W2158587776 countsByYear W21585877762015 @default.
- W2158587776 countsByYear W21585877762016 @default.
- W2158587776 countsByYear W21585877762017 @default.
- W2158587776 countsByYear W21585877762018 @default.
- W2158587776 countsByYear W21585877762019 @default.
- W2158587776 countsByYear W21585877762020 @default.
- W2158587776 countsByYear W21585877762021 @default.
- W2158587776 countsByYear W21585877762022 @default.
- W2158587776 countsByYear W21585877762023 @default.
- W2158587776 crossrefType "journal-article" @default.
- W2158587776 hasAuthorship W2158587776A5006031151 @default.
- W2158587776 hasAuthorship W2158587776A5063820246 @default.
- W2158587776 hasAuthorship W2158587776A5072329928 @default.
- W2158587776 hasAuthorship W2158587776A5089810822 @default.
- W2158587776 hasConcept C104317684 @default.
- W2158587776 hasConcept C105580179 @default.
- W2158587776 hasConcept C121608353 @default.
- W2158587776 hasConcept C150194340 @default.
- W2158587776 hasConcept C153911025 @default.
- W2158587776 hasConcept C159654299 @default.
- W2158587776 hasConcept C202751555 @default.
- W2158587776 hasConcept C203014093 @default.
- W2158587776 hasConcept C20418707 @default.
- W2158587776 hasConcept C2777991845 @default.
- W2158587776 hasConcept C2781190966 @default.
- W2158587776 hasConcept C502942594 @default.
- W2158587776 hasConcept C542903549 @default.
- W2158587776 hasConcept C54355233 @default.
- W2158587776 hasConcept C84425145 @default.
- W2158587776 hasConcept C86803240 @default.
- W2158587776 hasConcept C95444343 @default.
- W2158587776 hasConceptScore W2158587776C104317684 @default.
- W2158587776 hasConceptScore W2158587776C105580179 @default.
- W2158587776 hasConceptScore W2158587776C121608353 @default.
- W2158587776 hasConceptScore W2158587776C150194340 @default.
- W2158587776 hasConceptScore W2158587776C153911025 @default.
- W2158587776 hasConceptScore W2158587776C159654299 @default.
- W2158587776 hasConceptScore W2158587776C202751555 @default.
- W2158587776 hasConceptScore W2158587776C203014093 @default.
- W2158587776 hasConceptScore W2158587776C20418707 @default.
- W2158587776 hasConceptScore W2158587776C2777991845 @default.
- W2158587776 hasConceptScore W2158587776C2781190966 @default.
- W2158587776 hasConceptScore W2158587776C502942594 @default.
- W2158587776 hasConceptScore W2158587776C542903549 @default.
- W2158587776 hasConceptScore W2158587776C54355233 @default.
- W2158587776 hasConceptScore W2158587776C84425145 @default.
- W2158587776 hasConceptScore W2158587776C86803240 @default.
- W2158587776 hasConceptScore W2158587776C95444343 @default.
- W2158587776 hasFunder F4320320018 @default.
- W2158587776 hasIssue "10" @default.